The Recall Desk
HighFDA (Drugs)·D-0270-2026·Announced 2026-01-21

EXCEDRIN MIGRAINE 2'S recalled due to rodent exposure in distribution

Gold Star Distribution is recalling EXCEDRIN MIGRAINE 2'S nationwide due to insanitary conditions and rodent activity in their distribution center. The recall affects all lots currently within expiry.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is a risk-of-harm product (pharmaceutical drugs potentially exposed to rodent contamination in the distribution center) where no illnesses or injuries have been reported. The presence of rodent activity in a drug distribution facility represents a serious sanitation defect that could result in product contamination, meeting the rubric criterion for High severity.

Plain-English summary

Gold Star Distribution Inc. is recalling EXCEDRIN MIGRAINE 2'S- 25 CT tablets distributed nationwide. The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations at their distribution center, specifically insanitary conditions including rodent exposure and activity.

The recall affects all lots currently within their expiry date that were distributed by Gold Star Distribution. The insanitary conditions in the distribution facility present a potential risk of contamination to the affected product.

The recalled product

Product
EXCEDRIN MIGRAINE 2'S- 25 CT
Manufacturer
GOLD STAR DISTRIBUTION INC
Category
Drug
Hazard
  • rodent-exposure
  • sanitary-defect

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry distributed by Gold Star Distribution.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category